Q2
LONG ANSWER
10M
★ High-yield
Classify thyroid disorders. Describe Graves disease, Hashimoto thyroiditis and the carcinomas of the thyroid.
Classification of Thyroid Disease
| Group | Disorders |
|---|---|
| Hyperfunction | Graves disease, toxic multinodular goitre, toxic adenoma, thyroiditis (transient) |
| Hypofunction | Hashimoto thyroiditis, iodine deficiency, iatrogenic (surgery, radioiodine, drugs), congenital |
| Inflammation | Hashimoto, de Quervain (subacute granulomatous), Riedel, acute suppurative, silent/postpartum |
| Enlargement | Diffuse and multinodular goitre |
| Neoplasm | Follicular adenoma; papillary, follicular, medullary and anaplastic carcinoma; lymphoma |
Graves Disease
- The commonest cause of hyperthyroidism; women aged 20 to 40; female to male ratio 7:1
- An autoimmune type II hypersensitivity in which the antibody stimulates — thyroid-stimulating immunoglobulin binds the TSH receptor and mimics TSH, but is not subject to negative feedback
- The classical triad — hyperthyroidism with a diffuse goitre, infiltrative ophthalmopathy with exophthalmos, and pretibial myxoedema
- Morphology — diffusely enlarged, beefy red gland; tall crowded follicular cells with papillary infoldings, and "scalloped" colloid at the periphery where it is being resorbed; lymphoid aggregates
- Ophthalmopathy is caused by a separate mechanism — autoantibodies against retro-orbital fibroblasts cause glycosaminoglycan deposition, oedema and fibrosis of the extraocular muscles, so it does not resolve when the thyroid is treated
- Laboratory — TSH suppressed, free T4 and T3 raised, TSH receptor antibody positive, and diffuse increased uptake on isotope scan
Hashimoto Thyroiditis
- The commonest cause of hypothyroidism where iodine intake is adequate; women aged 45 to 65; female to male ratio 10:1 to 20:1
- Autoimmune destruction by type IV cell-mediated injury with cytotoxic T cells, plus antibody-dependent cytotoxicity
- Antibodies — anti-thyroid peroxidase (anti-TPO, the most sensitive) and anti-thyroglobulin
- Morphology — diffusely enlarged, firm, pale gland; dense lymphocytic infiltrate with germinal centres, atrophic follicles, and hurthle (Askanazy) cells — follicular cells with abundant granular eosinophilic cytoplasm packed with mitochondria
- May pass through a transient thyrotoxic phase ("hashitoxicosis") as stored hormone is released from damaged follicles, before hypothyroidism supervenes
- Associations — other autoimmune disease (type 1 diabetes, pernicious anaemia, Addison, vitiligo); a small but real increased risk of thyroid lymphoma
CLINICAL PEARL
Graves and Hashimoto are the same immunological accident with opposite results. Both are autoimmune, both target the thyroid, and both may occur in the same family. In Graves the antibody stimulates the TSH receptor; in Hashimoto cell-mediated injury destroys the gland. Stating that contrast first makes the rest of the comparison follow.
Other Thyroiditis and Goitre
| Condition | Features |
|---|---|
| DE quervain (subacute granulomatous) thyroiditis | Follows a viral upper respiratory infection; a painful, tender gland with fever; granulomas around damaged follicles with giant cells; raised ESR; transient thyrotoxicosis then hypothyroidism then recovery; low isotope uptake |
| Subacute lymphocytic (silent, postpartum) thyroiditis | Painless; within a year of delivery; lymphocytic infiltrate without germinal centres; usually self-limiting |
| RIEDEL thyroiditis | Rare; dense fibrosis extending beyond the capsule into surrounding structures, producing a stony-hard gland that mimics carcinoma; part of the IgG4-related disease spectrum |
| Diffuse and multinodular goitre | Impaired hormone synthesis, most often iodine deficiency, raises TSH and causes hyperplasia; alternating hyperplasia and involution produce nodularity, haemorrhage, fibrosis and calcification. May become toxic (Plummer syndrome) or cause pressure symptoms |
- A painful thyroid with low isotope uptake and a high ESR is de Quervain thyroiditis; low uptake with thyrotoxicosis is the key to distinguishing it from Graves disease, where uptake is high
- Endemic goitre from iodine deficiency was formerly widespread in the sub-Himalayan belt of India, and universal salt iodisation has greatly reduced it — one of the country’s major public health successes
Thyroid Carcinoma
| Type | Share | Features | Spread and prognosis |
|---|---|---|---|
| Papillary | 75–85% | "ORPHAN ANNIE eye" nuclei — optically clear, ground-glass; nuclear grooves and intranuclear pseudo-inclusions; psammoma bodies; papillae with fibrovascular cores. Associated with radiation exposure and BRAF/RET rearrangement | Lymphatic spread to cervical nodes; excellent prognosis, over 95% at 10 years, even with nodal disease |
| Follicular | 10–20% | Uniform follicles; diagnosis requires capsular or vascular invasion, which is why FNAC cannot distinguish it from a follicular adenoma. Commoner in iodine-deficient areas | Haematogenous spread to bone and lung; good but less favourable |
| Medullary | About 5% | Arises from parafollicular C cells; secretes calcitonin; sheets of polygonal cells in an amyloid stroma (Congo red positive). About 20% are familial, with RET mutation, as part of men 2A and 2B | Both lymphatic and haematogenous; intermediate prognosis |
| Anaplastic | Under 5% | Elderly; often on a background of long-standing goitre or differentiated carcinoma; wildly pleomorphic giant and spindle cells | Rapidly fatal — median survival a few months; presents with a rapidly enlarging mass, hoarseness and stridor |
Comparison of the Two Autoimmune Thyroid Diseases
| Feature | Graves disease | Hashimoto thyroiditis |
|---|---|---|
| Functional state | HYPERthyroid | HYPOthyroid (after a possible transient toxic phase) |
| Mechanism | Type II hypersensitivity — stimulating antibody to the TSH receptor | Type IV cell-mediated destruction plus antibody |
| Antibodies | TSH receptor antibody (thyroid-stimulating immunoglobulin) | Anti-TPO and anti-thyroglobulin |
| Gland | Diffusely enlarged, soft, beefy red and vascular, with a bruit | Diffusely enlarged, firm, pale, rubbery |
| Histology | Tall crowded cells with papillary infoldings; scalloped colloid | Lymphocytes with germinal centres; hurthle cells; atrophic follicles |
| Isotope uptake | High and diffuse | Low or patchy |
| Eye signs | Exophthalmos and ophthalmoplegia (infiltrative) | Absent (lid lag only if transiently toxic) |
| Long-term risk | Relapse; hypothyroidism after treatment | Thyroid lymphoma (small but real) |
Applied Aspects
- FNAC is the investigation of choice for a thyroid nodule, and reliably diagnoses papillary, medullary and anaplastic carcinoma — but cannot distinguish follicular adenoma from follicular carcinoma, which requires examination of the capsule in a resected specimen
- Features suggesting malignancy in a nodule — a solitary hard fixed nodule, rapid growth, hoarseness, cervical lymphadenopathy, previous neck irradiation, age under 20 or over 60, and male sex
- A "cold" nodule on isotope scanning carries a higher risk of malignancy than a hot one, though most cold nodules are still benign
- Serum calcitonin is the tumour marker for medullary carcinoma, and thyroglobulin is used to detect recurrence of differentiated carcinoma after total thyroidectomy
- Screen relatives for RET mutation when medullary carcinoma is diagnosed; prophylactic thyroidectomy is offered to carriers, and phaeochromocytoma must be excluded before any surgery in men 2
- Thyroid function tests in India must be interpreted with care in pregnancy, where reference ranges differ and untreated hypothyroidism impairs fetal neurodevelopment
- Papillary carcinoma may present as a cervical lymph node with an impalpable primary, and nodal metastasis does not worsen the excellent prognosis appreciably
- Radioiodine ablation after total thyroidectomy destroys residual thyroid tissue and allows thyroglobulin to be used as a sensitive marker of recurrence
- Anaplastic carcinoma is not curable, and treatment is directed at securing the airway and palliating symptoms rather than at cure
All questions in Endocrine, Bone & Breast Pathology
- Q1Classify diabetes mellitus. Differentiate type 1 from type 2 and describe the pathogenesis, morphology of complications and acute metabolic emergencies. ★
- Q2Classify thyroid disorders. Describe Graves disease, Hashimoto thyroiditis and the carcinomas of the thyroid. ★
- Q3Describe Cushing syndrome with its causes and investigation. Add notes on adrenal insufficiency, phaeochromocytoma and pituitary disorders. ★
- Q4Classify breast lesions. Describe the risk factors, classification, morphology and prognostic factors of breast carcinoma. ★
- Q5Describe the metabolic bone diseases. Add notes on osteomyelitis and the classification and features of bone tumours. ★
- SN1Describe the multiple endocrine neoplasia syndromes. ★
- SN2Define osteoporosis. Describe its causes, pathogenesis and diagnosis. ★
- SN3Describe fibroadenoma of the breast and differentiate it from a phyllodes tumour. ★
- SN4Define goitre. Describe the causes and pathogenesis of simple and multinodular goitre. ★
- SN5Describe carcinoma of the cervix with its aetiology, precursor lesions and prevention. ★
- SN6Describe gestational trophoblastic disease. Differentiate complete from partial mole and add a note on choriocarcinoma.
- SN7Describe hypothyroidism and hyperthyroidism with their causes, features and the interpretation of thyroid function tests. ★